Medicare Enrolled

Dr. Lance Freeman, M.D.

Endocrinology · Tallahassee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2633 CENTENNIAL BLVD STE 100, Tallahassee, FL 32308
8504315404
In practice since 2008 (17 years)
NPI: 1205097565 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Freeman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Freeman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Freeman

Dr. Lance Freeman is an endocrinology in Tallahassee, FL, with 17 years in practice. Based on federal Medicare data, Dr. Freeman performed 1,378 Medicare services across 275 unique beneficiaries.

Between the years covered by Open Payments, Dr. Freeman received a total of $2,846 from 36 pharmaceutical and/or device companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Freeman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 36% volume in FL$ $2,846 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,378
Medicare services
Top 36% in FL for endocrinology
275
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)960$19$34
Office visit, established patient (30-39 min)181$90$205
Office visit, established patient, complex (40-54 min)136$130$290
Office visit, established patient (20-29 min)41$56$152
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report36$25$68
Hospital follow-up visit, moderate complexity24$52$116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,846
Total received (2018-2024)
Avg $407/year across 7 years
Bottom 47% in FL for endocrinology
36
Companies
112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,846 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$650
2023
$490
2022
$665
2021
$68
2020
$159
2019
$764
2018
$50

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$310
Amgen Inc.
$269
BETA BIONICS, INC.
$252
Novo Nordisk Inc
$250
SANOFI-AVENTIS U.S. LLC
$219
Lilly USA, LLC
$212
Dexcom, Inc.
$139
Horizon Therapeutics plc
$126
AstraZeneca Pharmaceuticals LP
$126
Corcept Therapeutics
$120
Amarin Pharma Inc.
$69
Medtronic, Inc.
$66
Xeris Pharmaceuticals, Inc.
$57
Janssen Pharmaceuticals, Inc
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
ABBVIE INC.
$54
Novartis Pharmaceuticals Corporation
$46
AbbVie, Inc.
$44
Astellas Pharma US Inc
$41
Valeritas, Inc.
$39
Radius Health, Inc.
$38
Ipsen Biopharmaceuticals, Inc
$28
SANOFI PASTEUR INC.
$27
Merck Sharp & Dohme Corporation
$27
Ascendis Pharma Inc
$20
Nevro Corp.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Tandem Diabetes Care, Inc.
$17
Kowa Pharmaceuticals America, Inc.
$16
Alexion Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$15
Shire North American Group Inc
$13
Chiesi USA, Inc.
$13
AbbVie Inc.
$12
Medtronic MiniMed, Inc.
$12
Ferring Pharmaceuticals Inc.
$11
Top 3 companies account for 29.2% of total payments
Associated products mentioned in payments ›
DIABETES - DISEASE · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · HYPERLIPIDEMIA - DISEASE · INCRELEX · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · Livalo · MINIMED 780G · MOUNJARO · MYALEPT · Minimed 630G · NATPARA (PARATHYROID HORMONE) · NO PRODUCT DISCUSSED · Ozempic · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOMATULINE DEPOT · SYNTHROID · Senza · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · Tymlos · V-GO · Vascepa · Veozah · Wegovy · XARELTO · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $207 per 100 Medicare services performed
Looking for a endocrinology in Tallahassee?
Compare endocrinologys in the Tallahassee area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
6
Per 100K population
2.0
County median income
$65,074
Nearest hospital
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Freeman is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Freeman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Freeman performed 960 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Freeman receive payments from pharmaceutical companies?
Yes. Dr. Freeman received a total of $2,846 from 36 companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Freeman's costs compare to other endocrinologys in Tallahassee?
Dr. Freeman's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Freeman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →